Predictors of delayed sputum smear and culture conversion among a portuguese population with pulmonary tuberculosis;Preditores de conversão tardia dos exames micobacteriológicos direto e cultural de expetoração numa população portuguesa com tuberculose pulmonary.

Revista Portuguesa de Pneumologia

Volumn 18, Issue 2, 2012, Pages 72-79

  Caetano Mota, P ^a   Carvalho, A ^b,c   Valente, I ^c   Braga, R ^c   Duarte, R ^b,c,d  

^a Universidade do Porto   (Portugal)

^b Centro de Diagnostico Pneumologico de Vila Nova de Gaia   (Portugal)

^c CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^d University of Porto   (Portugal)

Author keywords

Culture; Delayed conversion; Smear; Sputum; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; ARTICLE; BACTERIAL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; EVALUATION; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SPUTUM CULTURE; SPUTUM SMEAR;

EID: 84858699327     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rppneu.2011.12.005     Document Type: Article

References (42)

1. World Health Organization. Treatment of Tuberculosis. Guidelines for National Programmes, 4th ed. World Health Organization Document 2010;WHO/HTM/TB/2009.420:1-147.
2. Epstein MD, Schluger NW, Davidow AL, Bonk S, Rom WN, Hanna B. Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest. 1998;113:379-86.
3. Mitchison DA. Infectivity of patients with pulmonary tuberculosis during chemotherapy. Eur Respir J. 1990;3:385-6.
4. Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1980;121:939-49.
5. Brooks SM, Lassiter NL, Young EC. A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. Am Rev Respir Dis. 1973;108:799-804.
6. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group. Factors influencing time to smear conversion in patients with smearpositive pulmonary tuberculosis. Respirology. 2009;14:1012-9.
7. Clancy L. Infectiousness of tuberculosis. Bull Int Union Tuberc Lung Dis. 1990;65:70.
8. Rieder HL. Sputum smear conversion during directly observed treatment for tuberculosis. Tuber Lung Dis. 1996;77:124-9.
9. Lienhardt C, Manneh K, Bouchier V, Lahai G, Milligan PJ, McAdam KP. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia. Int J Tuberc Lung Dis. 1998;2:712-8.
10. Ramarokoto H, Randriamiharisoa H, Rakotoarisaonina A, Rasolovavalona T, Rasolofo V, Chanteau S, et al. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. Int J Tuberc Lung Dis. 2002;6:909-12.
11. Singla R, Osman MM, Khan N, Al-Sharif N, Al-Sayegh MO, Shaikh MA. Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment. Int J Tuberc Lung Dis. 2003;7:58-64.
12. Abal AT, Jayakrishnan B, Parwer S, El Shamy A, Abahussain E, Sharma PN. Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis. Respir Med. 2005;99:415-20.
13. Gopi PG, Chandrasekaran V, Subramani R, Santha T, Thomas A, Selvakumar N, et al. Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen. Indian J Med Res. 2006;123:807-14.
14. Salaniponi FM, Christensen JJ, Gausi F, Kwanjana JJ, Harries AD. Sputum smear status at two months and subsequent treatment outcome in new patients with smear-positive pulmonary tuberculosis. Int J Tuberc Lung Dis. 1999;3:1047-8.
15. Güler M, Unsal E, Dursun B, Aydln O, Capan N. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Int J Clin Pract. 2007;61:231-5.
16. Gullón JA, Suárez I, Lecuona M, Fernández R, Rubinos G, Medina A, et al. Time to culture conversion in smokers with pulmonary tuberculosis. Monaldi Arch Chest Dis. 2009;71: 127-31.
17. Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, et al. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med. 2006 2;144: 650-9.
18. Banu Rekha VV, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V, et al. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors. Indian J Med Res. 2007;126:452-8.
19. Vidal R, Martin-Casabona N, Juan A, Falgueras T, Miravitlles M. Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment. Chest. 1996;109:1562-5.
20. Al-Moamary MS, Black W, Bessuille E, Elwood RK, Vedal S. The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest. 1999;116: 726-31.
21. Lee JS, Kim EC, Joo SI, Lee SM, Yoo CG, Kim YW, et al. The incidence and clinical implication of sputum with positive acidfast bacilli smear but negative in mycobacterial culture in a tertiary referral hospital in South Korea. J Korean Med Sci. 2008;23:767-71.
22. Horne DJ, Royce SE, Gooze L, Narita M, Hopewell PC, Nahid P, et al. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis. 2010;10:387-94.
23. Humbwavali JB, Trujillo NJ, Paim BS, Wolff FH, Barcellos NT. Sputum monitoring during tuberculosis treatment for predicting outcome. Lancet Infect Dis. 2011;11:160, author reply 160-1.
24. Su WJ, Feng JY, Chiu YC, Huang SF, Lee YC. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis. Eur Respir J. 2011;37:376-83.
25. Diagnostic Standards, Classification of Tuberculosis in Adults, Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000;161(4 Pt. 1):1376-95.
26. Forbes BA, Sahm DF, Weissfeld AS. Mycobacteria. In: Bailey & Scott's Diagnostic Microbiology. 11st ed. Mosby: St. Louis, MO; 2002. p. 552.
27. Duarte R, Carvalho A, Ferreira D, Saleiro S, Lima R, Mota M, et al. Tuberculosis treatment and management of some problems related to the medication. Rev Port Pneumol. 2010;16:559-72.
28. Horne DJ, Johnson CO, Oren E, Spitters C, Narita M. How soon should patients with smear-positive tuberculosis be released from inpatient isolation? Infect Control Hosp Epidemiol. 2010;31:78-84.
29. Programa Nacional de Luta contra a Tuberculose. Ponto da Situac ̧ão Epidemiológica e de desempenho. 2010 (version in March 2011):2-33.
30. Fortún J, Martín-Dávila P, Molina A, Navas E, Hermida JM, Cobo J, et al. Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? J Antimicrob Chemother. 2007;59:794-8.
31. Kuaban C, Bame R, Mouangue L, Djella S, Yomgni C. Nonconversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon. East Afr Med J. 2009;86:219-25.
32. Kim TC, Blackman RS, Heatwole KM, Kim T, Rochester DF. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment. Am Rev Respir Dis. 1984;129:264-8.
33. Domínguez-Castellano A, Muniain MA, Rodriguez-Baño J, Garcia M, Rios MJ, Galvez J, et al. Factors associated with time to sputum smear conversion in active pulmonary tuberculosis. Int J Tuberc Lung Dis. 2003;7:432-8.
34. Liu Z, Shilkret KL, Ellis HM. Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence. Arch Intern Med. 1999;159:1110-6.
35. Telzak EE, Fazal BA, Pollard CL, Turett GS, Justman JE, Blum S. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis. 1997;25:666-70.
36. Canetti G. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965;92:687-703.
37. Hobby GL, Holman AP, Iseman MD, Jones JM. Enumeration of tubercle bacilli in sputum of patients with pulmonarytuberculosis. Antimicrob Agents Chemother. 1973;4:94-104.
38. Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007;11:1049-61.
39. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 2007;4:e20.
40. Zellweger JP. Tobacco and tuberculosis. Monaldi Arch Chest Dis. 2008;69:83-5.
41. Leung CC, Lam TH, Ho KS, Yew WW, Tam CM, Chan WM, et al. Passive smoking and tuberculosis. Arch Intern Med. 2010;170:287-92.
42. Senkoro M, Mfinanga SG, Mørkve O. Smear microscopy and culture conversion rates among smear positive pulmonary tuberculosis patients by HIV status in Dar es Salaam, Tanzania. BMC Infect Dis. 2010;10:210.